Dissecting cell type-specific chromatin dynamics driven by oncogenic JAK-STAT signaling


JAK-STAT signaling is vital for the development, survival and response of immune cells. Intriguingly, members of the JAK-STAT pathway are frequently mutated in cancer and are known to drive several haematopoietic malignancies. Based on our observation that key regulatory regions of myeloid development are specifically hypermethylated in the lymphoid lineage, we hypothesize that oncogenic transformation by aberrant STAT activity is dependent on a permissive epigenome.

To identify cell type-specific differences in the response to JAK-STAT signalling, we will isolate specific lymphoid and myeloid cell populations from wild-type and STAT-deficient mice and analyse their epigenome and transcriptome response upon treatment with STAT-activating cytokines. The cross-talk between JAK-STAT signaling and the epigenome will be investigated using in vivo transplants of retrovirally transformed bone marrow harbouring known STAT3 and STAT5 mutations, which will provide a basis for dissecting the epigenome dynamics of oncogenic transformation.

The ensuing insights into STAT-induced oncogenic reprogramming of the epigenome could potentially contribute to the development of precision therapies for STAT-driven leukaemia.


SFB-F61 / F28 related publications - Group Bock

Halbritter, F., Farlik, M., Schwentner, R., Jug, G., Fortelny, N., Schnoller, T., Pisa, H., Schuster, L. C., Reinprecht, A., Czech, T., Gojo, J., Holter, W., Minkov, M., Bauer, W. M., Simonitsch-Klupp, I., Bock, C. and Hutter, C.
Epigenomics and Single-cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis
Journal: Cancer Discov

Cancer Discov. 2019 Jul 25. pii: 2159-8290.CD-19-0138. doi: 10.1158/2159-8290.CD-19-0138
Simonovic, N., Witalisz-Siepracka, A., Meissl, K., Lassnig, C., Reichart, U., Kolbe, T., Farlik, M., Bock, C., Sexl, V., Müller, M. and Strobl, B.
NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity
J Immunol. 2019 Feb 4. pii: jimmunol.1701649. doi: 10.4049/jimmunol.1701649
Baumgartner, C., Toifl, S., Farlik, M., Halbritter, F., Scheicher, R., Fischer, I., Sexl, V., Bock, C. and Baccarini, M. (2018)
An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion
Cell Stem Cell. 2018 May 17. pii: S1934-5909(18)30221-2. doi: 10.1016/j.stem.2018.05.003
Pham, H.T.T., Maurer, B., Prchal-Murphy, M., Grausenburger, R., Grundschober, E., Javaheri, T., Nivarthi, H., Boersma, A., Kolbe, T., Elabd, M., Halbritter, F., Pencik, J., Kazemi, Z., Grebien, F., Hengstschlager, M., Kenner, L., Kubicek, S., Farlik, M., Bock, C., Valent, P., Muller, M., Rulicke, T., Sexl, V., and Moriggl, R. (2018).
STAT5BN642H is a driver mutation for T cell neoplasia.
J Clin Invest 128, 387-401
Milosevic Feenstra, J.D., Nivarthi, H., Gisslinger, H., Leroy, E., Rumi, E., Chachoua, I., Bagienski, K., Kubesova, B., Pietra, D., Gisslinger, B., Milanesi, C., Jager, R., Chen, D., Berg, T., Schalling, M., Schuster, M., Bock, C., Constantinescu, S.N., Cazzola, M., and Kralovics, R. (2016).
Whole exome sequencing identifies novel MPL and JAK2 mutations in triple negative myeloproliferative neoplasms.
Blood 127, 325-332
Kollmann, K., Heller, G., Schneckenleitner, C., Warsch, W., Scheicher, R., Ott, R.G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., Reichart, U., Mayerhofer, M., Hoeller, C., Zöchbauer-Müller, S., Kerjaschki, D., Bock, C., LKenner, L., Hoefler, G., Freissmuth, M., Green, A.R., Moriggl, R., Busslinger, M., Malumbres, M., and Sexl, V. (2013).
A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis.
Cancer Cell 24: 167-181. doi: dx.doi.org/10.1016/j.ccr.2013.07.012